D&D Pharmatech (347850.KQ)
KRW 47200.0
(0.21%)
KRW 47200.0
(0.21%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -13.48 Billion KRW | 80.36% |
| 2022 | -68.65 Billion KRW | 9.28% |
| 2021 | -75.67 Billion KRW | -9.51% |
| 2020 | -69.1 Billion KRW | -121.97% |
| 2019 | -31.13 Billion KRW | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.94 Billion KRW | -36.29% |
| 2024 Q1 | -4.36 Billion KRW | -9.64% |
| 2023 Q4 | -3.97 Billion KRW | -41396.7% |
| 2023 FY | -13.48 Billion KRW | 80.36% |
| 2023 Q3 | -9.59 Million KRW | -100.21% |
| 2023 Q2 | 4.51 Billion KRW | 217.35% |
| 2023 Q1 | -3.84 Billion KRW | 72.2% |
| 2022 FY | -68.65 Billion KRW | 9.28% |
| 2022 Q4 | -13.84 Billion KRW | 0.0% |
| 2021 FY | -75.67 Billion KRW | -9.51% |
| 2020 FY | -69.1 Billion KRW | -121.97% |
| 2019 FY | -31.13 Billion KRW | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HLB Co., Ltd. | -125.02 Billion KRW | 89.213% |
| iNtRON Biotechnology, Inc. | -3.28 Billion KRW | -310.545% |
| BINEX Co., Ltd. | 1.04 Billion KRW | 1393.939% |
| Bioneer Corporation | 791.75 Million KRW | 1803.341% |
| Anterogen.Co.,Ltd. | -5.07 Billion KRW | -165.8% |
| MEDIPOST Co., Ltd. | -25.13 Billion KRW | 46.336% |
| CrystalGenomics, Inc. | -30.91 Billion KRW | 56.373% |
| Helixmith Co., Ltd | -35.24 Billion KRW | 61.736% |
| Chabiotech Co.,Ltd. | -9.42 Billion KRW | -43.087% |
| Medy-Tox Inc. | 17.32 Billion KRW | 177.855% |
| Peptron, Inc. | -15.6 Billion KRW | 13.566% |
| Amicogen, Inc. | 2.05 Billion KRW | 755.901% |
| Genexine, Inc. | -41.24 Billion KRW | 67.299% |
| HLB Therapeutics Co.,Ltd. | -8.7 Billion KRW | -55.01% |
| LegoChem Biosciences, Inc. | -80.82 Billion KRW | 83.314% |
| ALTEOGEN Inc. | -9.73 Billion KRW | -38.507% |
| PharmaResearch Co., Ltd. | 100.81 Billion KRW | 113.377% |
| SillaJen, Inc. | -21.34 Billion KRW | 36.82% |
| JETEMA, Co., Ltd. | 2.63 Billion KRW | 612.077% |
| OliX Pharmaceuticals,Inc | -18.18 Billion KRW | 25.84% |
| Genomictree Inc. | -17.3 Billion KRW | 22.061% |
| MedPacto, Inc. | -28.75 Billion KRW | 53.095% |
| EASY BIO,Inc. | 20.63 Billion KRW | 165.368% |
| GI Innovation, Inc. | -55.6 Billion KRW | 75.746% |